Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» hepatitis C
hepatitis C
Pharmasset climbs after study result released
Yahoo/AP
Tue, 09/6/11 - 12:44 pm
hepatitis C
Pharmasset
PSI-7977
Buying Into a Hot Hepatitis C Drug Market
Minyanville
Thu, 08/25/11 - 03:44 pm
hepatitis C
Pharmasset
Vertex
Merck
Achillion
Indenix
Inhibitex
INX-189
Incivek
Victrelis
Vertex Pharma receives Canadian OK for Incivek
Yahoo/AP
Mon, 08/22/11 - 11:50 am
Vertex Pharmaceuticals
Canada
Incivek
hepatitis C
Could Vertex Sell $1 Billion Of Its Hepatitis C Drug This Year?
Forbes
Fri, 08/19/11 - 10:58 am
Vertex Pharmaceuticals
hepatitis C
Incivek
Analyst touts Pharmasset shares
Yahoo/AP
Sat, 08/13/11 - 02:46 pm
Pharmasset
analysis
PSI-7977
hepatitis C
DOJ Subpoena May Rattle Old Skeletons in Merck’s Closet
BNET Pharma
Wed, 08/10/11 - 10:50 am
hepatitis C
melanoma
cancer
Intron A
Temodar
DOJ
PegIntron
Merck
Merck gets subpoena tied to marketing of 3 drugs
Yahoo/AP
Mon, 08/8/11 - 11:21 am
Merck
Temodar
PegIntron
Intron A
hepatitis C
Schering Plough
Merck: Don't declare a hep C victor yet
Fierce Pharma
Tue, 08/2/11 - 12:40 pm
Merck
Vertex Pharmaceuticals
Incivek
hepatitis C
Victrelis
Vertex Pharmaceuticals Beats Merck in Hepatitis C Drug Sales
Bloomberg
Sat, 07/30/11 - 09:51 am
Vertex Pharmaceuticals
Merck
Incivek
Victrelis
hepatitis C
Vertex 4-drug hepatitis C combo shows promise
Reuters
Wed, 07/27/11 - 10:40 am
Vertex Pharmaceuticals
hepatitis C
VX-222
Incivek
pegylated interferon
ribaviron
Ligand trades higher on study of Promacta drug
Yahoo/AP
Tue, 07/26/11 - 01:54 pm
Promacta
Ligand
GSK
hepatitis C
J&J Wins European Panel’s Backing of Cancer, Hepatitis Drugs
Bloomberg
Sat, 07/23/11 - 04:32 pm
JNJ
Incivo
hepatitis C
Zytiga
prostate cancer
5 Biotech Drug-Launch Stocks to Watch
TheStreet.com
Mon, 07/18/11 - 10:03 am
Human Genome Sciences
Vertex Pharmaceuticals
Acorda Therapeutics
Dendreon
Avanir
lupus
Benlysta
Incivek
hepatitis C
MS
AMPYRA
Provenge
prostate cancer
Nuedexta
PBA
J&J Has to Resolve Hepatitis C Drug Conflict, Medivir CEO Says
Bloomberg
Wed, 07/13/11 - 08:23 am
Medivir
JNJ
hepatitis C
Incivek
Tibotec
TMC435
Vertex Pharmaceuticals
J&J's Been Busy
Motley Fool
Thu, 07/7/11 - 07:39 pm
JNJ
HIV
Gilead Sciences
Pharmasset
hepatitis C
Vertex Tops Merck in Early Hep C Drug Launch
TheStreet.com
Tue, 06/28/11 - 09:22 am
hepatitis C
Merck
Vertex Pharmaceuticals
Incivek
Victrelis
Vertex Pharma licenses 2 oral hepatitis C drug candidates from Alios BioPharma
Yahoo/AP
Mon, 06/13/11 - 10:06 am
Vertex Pharmaceuticals
Allos
hepatitis C
Pharmasset shares climb after company expands study of hepatitis C drug candidate PSI-7977
Yahoo/AP
Wed, 06/8/11 - 09:36 am
Pharmasset
hepatitis C
PSI-7977
Pharmasset rises as analyst says hepatitis C drug could be approved in 2014, raises target
Yahoo/AP
Fri, 06/3/11 - 10:40 am
Pharmasset
hepatitis C
Vertex to field small, specialized sales force on Incivek
Fierce Pharma
Thu, 05/26/11 - 12:27 pm
drug reps
sales force
Vertex Pharmaceuticals
hepatitis C
Incivek
Pages
« first
‹ previous
…
39
40
41
42
43
44
45
46
47
…
next ›
last »